Coronary Thrombectomy Device Market - US - Units Sold, Average Selling Prices, Product Pipeline, Forecasts - 2018-2024| MedCore

Coronary Thrombectomy Device Market - US - Units Sold, Average Selling Prices, Product Pipeline, Forecasts - 2018-2024| MedCore

  • March 2018 •
  • 577 pages •
  • Report ID: 5365799 •
  • Format: PDF
Since a thrombectomy is performed in a certain percentage of PCI procedures, as procedure growth remained flat over the last few years, so have thrombectomy device sales. As procedure growth begins to stabilize, unit sales of thrombectomy devices will also rebound. Over the forecast period, the number thrombectomy devices sold for coronary applications is expected to increase. However, the price for a thrombectomy device has been decreasing at a higher rate than unit growth, resulting in a net decrease for the overall market.

Abstract
Thrombectomy is the process by which an intravascular catheter is used to remove or aspirate obstructing particles from the bloodstream. Thrombosis is a disease state that occurs when dislodged blood clots or thrombi block the normal flow of blood through a vessel, causing complications, such as myocardial infarction or stroke. Most thrombi are produced when vulnerable plaque ruptures and the fragments are released into the bloodstream. The intravascular coagulation of blood cells is primarily responsible for the development of thrombi.

Scope
2014-2024